News & Updates

Germline genetic testing registers low numbers

07 Jun 2023

The adoption rate of germline genetic testing among individuals diagnosed with cancer in some states in the US over a period of 6 years remains subpar, with only 6.8 percent undergoing testing, as reported in a study.

Germline genetic testing registers low numbers

07 Jun 2023

Organ sparing may predispose genitourinary rhabdomyosarcoma patients to extra surgery

06 Jun 2023

Patients with genitourinary rhabdomyosarcoma who undergo organ-sparing treatment have higher odds of additional reconstructive surgery due to compromised urological function, reports a study.

Organ sparing may predispose genitourinary rhabdomyosarcoma patients to extra surgery

06 Jun 2023

Does extended lymph node sampling increase complications?

06 Jun 2023

Patients undergoing more extensive lymph node sampling during surgery for a suspected malignant paediatric renal tumour do not appear to have a higher likelihood of experiencing clinically significant complications, reveals a study.

Does extended lymph node sampling increase complications?

06 Jun 2023

Nivolumab-chemo poised to alter NSCLC treatment landscape

06 Jun 2023 by

In the 3-year analysis of the phase III CheckMate 816 trial, neoadjuvant nivolumab plus platinum doublet chemotherapy (nivo-chemo) continued to provide durable benefit for individuals with resectable non-small-cell lung cancer (NSCLC).

Nivolumab-chemo poised to alter NSCLC treatment landscape

06 Jun 2023

Adjuvant cisplatin-gemcitabine ups PFS vs cisplatin-fluorouracil in N2–3 NPC after cCRT

06 Jun 2023 by

In Chinese patients with stage N2–3 nasopharyngeal carcinoma (NPC) who have completed concurrent chemoradiotherapy (cCRT), adjuvant cisplatin-gemcitabine significantly improves progression-free survival (PFS) vs current standard of care (SoC) with adjuvant cisplatin-fluorouracil, according to a phase III trial at four cancer centres in China that was reported at ASCO 2023.

Adjuvant cisplatin-gemcitabine ups PFS vs cisplatin-fluorouracil in N2–3 NPC after cCRT

06 Jun 2023

Camrelizumab plus apatinib and temozolomide delivers in advanced acral melanoma

05 Jun 2023

The combination of camrelizumab plus apatinib and temozolomide appears to be beneficial in the first-line treatment of advanced acral melanoma, with the majority of the patients showing response and an acceptable safety profile, according to the results of a phase II study.

Camrelizumab plus apatinib and temozolomide delivers in advanced acral melanoma

05 Jun 2023

Sexual dysfunction in young cancer survivors tied to fatigue, worse sleep

04 Jun 2023

Female young adult cancer survivors (YACS) with sexual dysfunction show higher levels of fatigue, have worse sleep, and experience more frequent severe pain compared to those without sexual dysfunction, reports a study.

Sexual dysfunction in young cancer survivors tied to fatigue, worse sleep

04 Jun 2023

Fruit and vegetable intake lowers endometrial cancer risk

02 Jun 2023

Eating fruits and vegetables may help reduce the risk of endometrial cancer, suggests a recent study, noting that specific kinds of fruits and vegetables must be recommended based on their outstanding bioactive components.

Fruit and vegetable intake lowers endometrial cancer risk

02 Jun 2023

Original New Drug Application Approvals by US FDA (16-31 May 2023)

01 Jun 2023

New drug applications approved by US FDA as of 16-31 May 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 May 2023)

01 Jun 2023

Cancer incidence uncommon among low-risk pancreatic cysts during extended surveillance

31 May 2023

Low-risk branch duct intraductal papillary mucinous neoplasms (BD-IPMNs) appear to have a positive outlook, with the results of a recent meta-analysis showing that the incidence of advanced neoplasia during extended surveillance is low.

Cancer incidence uncommon among low-risk pancreatic cysts during extended surveillance

31 May 2023

News & Updates

Filter by Specialty:

Specialty:

Germline genetic testing registers low numbers

Germline genetic testing registers low numbers

Organ sparing may predispose genitourinary rhabdomyosarcoma patients to extra surgery

Organ sparing may predispose genitourinary rhabdomyosarcoma patients to extra surgery

Does extended lymph node sampling increase complications?

Does extended lymph node sampling increase complications?

Nivolumab-chemo poised to alter NSCLC treatment landscape

Nivolumab-chemo poised to alter NSCLC treatment landscape

Adjuvant cisplatin-gemcitabine ups PFS vs cisplatin-fluorouracil in N2–3 NPC after cCRT

Adjuvant cisplatin-gemcitabine ups PFS vs cisplatin-fluorouracil in N2–3 NPC after cCRT

Camrelizumab plus apatinib and temozolomide delivers in advanced acral melanoma

Camrelizumab plus apatinib and temozolomide delivers in advanced acral melanoma

Sexual dysfunction in young cancer survivors tied to fatigue, worse sleep

Sexual dysfunction in young cancer survivors tied to fatigue, worse sleep

Fruit and vegetable intake lowers endometrial cancer risk

Fruit and vegetable intake lowers endometrial cancer risk

Original New Drug Application Approvals by US FDA (16-31 May 2023)

Original New Drug Application Approvals by US FDA (16-31 May 2023)

Cancer incidence uncommon among low-risk pancreatic cysts during extended surveillance

Cancer incidence uncommon among low-risk pancreatic cysts during extended surveillance